| Health / Medical Topics |
Folate Binding Protein E39 Peptide Vaccine
A cancer vaccine comprised of human leukocyte antigen (HLA) A2 restricted folate binding protein (FBP) epitope E39 (amino acids 191 to 199), with potential immunostimulatory and antineoplastic activity. Upon intradermal injection, FBP E39 peptide vaccine may induce a specific cytotoxic T-lymphocyte (CTL) response against FBP-expressing tumor cell types. FBP is a membrane-bound, tumor-associated antigen highly overexpressed in various tumor cell types, such as in breast, ovarian and endometrial cancers; E 39 is a strong immunogenic peptide. (NCI Thesaurus)
YOU MAY ALSO LIKE
A type of drug that stops cells from using folic acid to make DNA and may kill cancer cells. Certain folate antagonists…
A nutrient in the vitamin B complex that the body needs in small amounts to function and stay healthy. Folate helps to…
A thin, flexible sheet of metal.
Issue associated with the visibility of water vapor in the immediate atmosphere in which the device is being used.
The international component of the National Institutes of Health (NIH) dedicated to advancing the mission of NIH by supporting and facilitating global…
Minimally invasive procedure for ablating tumors. The primary mechanism of tissue damage is thermal.
